Tags: Drug.
Drotrecogin alfa (activated) (Xigris marketed by Eli Lilly and Company) is a recombinant form of human activated protein C that has anti-thrombotic anti-inflammatory and profibrinolytic properties. Drotrecogin alpha (activated) belongs to the class of serine proteases. Drotrecogin alfa has not been found to improve outcomes in people with severe sepsis. The manufacturer’s aggressive strategies in marketing its use in severe sepsis have been criticized. On October 25 2011 Eli Lilly & Co.